Tag Archives: Myriad

Approaches to Claiming Diagnostic Methods using Biomarkers in the EPO

Posted on April 9, 2013 by Warren Woessner

Find linked below a guest post from Dr. Stefan Danner in regards to drafting diagnostic claims in Europe. Diagnostic Claims    

Posted in Patent Eligible Subject Matter | Tagged , , , , , , | Leave a comment

Time For Myriad To Fight Another Day

Posted on February 4, 2013 by Warren Woessner

Put another way, it is time for Jones Day to click their well-polished heels and go home. Today, the U.S. Government filed an amicus brief largely supporting the arguments by AMP/ACLU that isolated DNA is essentially the same molecule after … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , , , | 2 Comments

Top Ten Biotech IP Stories of 2012

Posted on December 28, 2012 by Warren Woessner

I admit, I am a sucker for lists, esp. Top Ten Lists, and a few days ago, sat through a half hour of “local news” wherein the anchors breathlessly related the Top Ten Rhode Island News Stories of 2012. Well, … Continue reading →

Posted in Miscellaneous | Tagged , , , , , , , , , , , | 2 Comments

Re-Election of Obama Keeps Patent Law and Policy on Track

Posted on November 7, 2012 by Warren Woessner

At least Director Kappos does not have to clean out his desk. The re-election of President Obama gives him another four years of job security – if he and his hard-working staff don’t burn out first. No matter what you … Continue reading →

Posted in Govt Policy/PTO Policy | Tagged , , , , , , , | Leave a comment